RE:RE:Melanoma & ColorectalYep - all good stuff. I passed the links along to an analyst to see if it would elicit any excitement or critique for us. Will see if it does. I'm guessing it's the kind of thing they would ignore until a Phase 1 complete or Phase 2. To me, finding something highly effective and massively more safe would be worth understanding. I'll see if he thinks so too.
scarlet1967 wrote: "The colorectal is also interesting since it does show docetaxel has basically no effect yet TH1902 does."
Great to see, the presentation was easy to follow ,couple of things were emphasized one low concentration (a quarter of the dose) of TH 1902 PDC showed full activity in TNB cancer, melanoma and endometrial cancer versus docetaxel alone not showing any activity when administered in low dose.
Docetaxel has no activity in colorectal cancer versus TH1902 PDC which showed significant activity.